Aura Biosciences Inc. (AURA)

7.21

-0.28 (-3.74%)

At close: Mar 03, 2025, 3:59 PM

6.45

-10.60%

Pre-market: Mar 04, 2025, 04:36 AM EST

Aura Biosciences Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19
Net Income	-76.41M	-58.76M	-35.25M	-22.21M	-24.2M
Depreciation & Amortization	1.29M	1.18M	831K	831K	509K
Stock-Based Compensation	8.77M	6.41M	2.31M	736K	507K
Other Working Capital	5.48M	-3.44M	-1.37M	-1.96M	1.42M
Other Non-Cash Items	-1.95M	-325K	4K	-3K	43K
Deferred Income Tax	n/a	n/a	14K	n/a	11K
Change in Working Capital	4.44M	-3.1M	-315K	-3.68M	2.46M
Operating Cash Flow	-63.85M	-54.6M	-32.41M	-24.32M	-20.67M
Capital Expenditures	-709K	-1.09M	-2.13M	-771K	-2.22M
Acquisitions	n/a	66.78K	n/a	n/a	n/a
Purchase of Investments	-233.65M	-119.78M	n/a	n/a	n/a
Sales Maturities Of Investments	120.4M	53.01M	n/a	n/a	n/a
Other Investing Acitivies	n/a	-66.78K	n/a	n/a	n/a
Investing Cash Flow	-113.96M	-67.87M	-2.13M	-771K	-2.22M
Debt Repayment	n/a	n/a	n/a	n/a	-37K
Common Stock Repurchased	n/a	n/a	n/a	n/a	-13K
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	94.12M	87.08M	87.56M	19.94M	39.76M
Financial Cash Flow	97.29M	95.63M	166.26M	10.04M	39.73M
Net Cash Flow	-80.52M	-26.84M	131.72M	-15.06M	16.84M
Free Cash Flow	-64.56M	-55.7M	-34.53M	-25.09M	-22.89M